Gene editing Archives

In Depth 26 Jul 2022

How DNA sequencing can safeguard against biodiversity loss

Preserving Earth’s biodiversity is crucial as we rely on healthy ecosystems for many services, from clean air and water to protection from floods and pandemics. DNA sequencing is an invaluable tool for characterizing biodiversity and informing conservation efforts. In Earth’s history, there have been five major mass extinction events — the most recent of which […]

July 26, 2022 - 8 minutesmins - By Omnia Ibrahim

News and Trends 25 Jul 2022

Replay launches with $55M to reprogram biology by writing and delivering big DNA

Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San Diego, Cal., and London, U.K., […]

July 25, 2022 - 3 minutesmins - By Jim Cornall

Patient dosed in phase 1 trial evaluating ATG-018 treatment

News and Trends 13 Jul 2022

Development of cancer therapeutics accelerated by end-to-end single-cell multi-omics services

Solid tumor assays have been launched by Mission Bio Inc., through its Pharma Assay Development (PAD) services. The availability of this new service offering from Mission Bio, a high-throughput single-cell DNA and multi-omics analysis company, will help accelerate the development of cancer therapeutics. It will do so by reducing the time and cost associated with […]

July 13, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Jul 2022

World’s first research project for an early detection, multi-cancer screening test launched in Singapore

A project for the discovery and validation of new combinations of biomarkers that can detect multi-cancer early has been launched in Singapore. Biotechnology company, MiRXES Ptr Ltd, announced this week the signing of a memorandum of understanding signaling the launch of Project CADENCE (Cancer Detected Early caN be CurEd). It is the world’s first large-scale […]

July 8, 2022 - 4 minutesmins - By Liza Laws

Liver body Promethera decade3d anatomy online 1

News and Trends 5 Jul 2022

Poxel publishes ALD studies

Two preclinical articles have been published in different journals for treatments being developed by French biopharmaceutical company, Poxel. Poxel develops treatments for chronic, serious diseases with metabolic pathophysiology including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders. The articles have been about genetic disease X-Linked Adrenoleukodystrophy (ALD) and molecules PXL065 and PXL770. These molecules have separate […]

July 5, 2022 - 3 minutesmins - By Liza Laws

In Depth 7 Mar 2022

Multiplexing Speeds up Writing and Editing DNA

While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications of genome engineering. Much of biotech is about reverse-engineering the designs that billions of years of evolution have put together. To be able to […]

March 7, 2022 - 6 minutesmins - By Sachin Rawat

News and Trends 1 Feb 2022

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and the storage of data as DNA. Supported by lead investor Hadean Ventures, Ribbon Biolabs’ fundraising round is part and parcel of a continuing investor interest […]

February 1, 2022 - 3 minutesmins - By Dan Samorodnitsky

News and Trends 14 Jan 2022

Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021

Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth. Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over 2021, said the advanced therapy advocacy organization the Alliance for Regenerative Medicine (ARM) in a briefing this week. This bumper […]

January 14, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 17 Dec 2021

UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI

Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited crops with the help of artificial intelligence tools. The firm expects to bring its first product, a weather-resistant tomato, to market in early 2022. The seed financing will fuel the development of Phytoform’s precision crop breeding platform, which specializes in […]

December 17, 2021 - 4 minutesmins - By Dan Samorodnitsky

In Depth 3 Nov 2021

CRISPR-Cas9: The Gene Editing Tool Changing the World

CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much easier and faster than ever before. But how does CRISPR actually work? How can biology research benefit from it? What will happen when we start using it to edit human DNA? And what’s the fight between its developers all about? […]

November 3, 2021 - 11 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Oct 2021

DNA Manufacturing Startups Net Venture Capital Windfalls

Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month as investor excitement mounts over the next generations of DNA manufacturing. DNA Script made a big splash in Paris this week as it raked in €142M in Series C funding. The company will ramp up the commercialization of its benchtop […]

October 28, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 22 Oct 2021

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the detection of an unexpected genetic change in a clinical trial. Industry experts see these events as a reality check for the nascent field. Off-the-shelf treatments that use genetically engineered T cells to treat diseases suffered […]

October 22, 2021 - 5 minutesmins - By Anita Chakraverty

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us